Do these 3 things before closing this tab:
1Repair Windows errors before they cause bigger problems2Scan for outdated or missing drivers - takes under a minute3Clear out junk files and repair common Windows errorsReperio Health announced on May 19, 2025, that it had closed a $14 million funding round led by Nashville-based Caduceus Capital Partners. The company said it would use the money to expand its at-home preventive-screening and ReperioCare virtual-consultation services. The distinction matters: Reperio said its screening kits were available in all 50 states, while clinician access was still being expanded state by state.
What the $14 million round funds
Reperio described the financing as support for scaling ReperioCare, expanding employer and health-plan partnerships, and extending virtual clinician access nationwide. The announcement did not disclose the company’s valuation, the round’s structure, a complete investor list, revenue, profitability, or customer concentration. Reperio’s May 2025 announcement is the source for the amount, lead investor, and stated use of proceeds.
The raise is best understood as funding a broader preventive-care service, not simply more shipments of a physical kit. National clinician coverage requires more than shipping: providers must be licensed and available in each state, and the company must build payer and employer arrangements, eligibility processes, billing operations, and clinical escalation workflows.
What Reperio sells
ReperioKit: an at-home screening workflow
Reperio mails a kit containing Bluetooth-connected devices and guides users through measurements in an app. The company says the kit provides results for blood pressure, heart rate, body mass index, relative fat mass, blood glucose, total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides. Reperio describes the devices as FDA-cleared; that claim applies to devices, not necessarily to the complete Reperio service or every element of its workflow.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
#1 Best Overall
- ✅ 6-IN-1 COMPREHENSIVE WELLNESS SCREENING This all-in-one self-check panel evaluates six key feminine wellness indicators in one simple test, helping you better understand changes related to intimate balance and daily comfort. Support a more complete personal wellness routine with convenient at-home monitoring.
- ✅ Fast, Clear and Trustworthy At-Home Results Adopts premium colloidal gold testing technology to deliver stable and easy-to-interpret results in only 10–15 minutes. Skip crowded clinics and long waiting times, get intuitive feedback conveniently at home for your daily feminine wellness routine.
- ✅ Gentle Non-Invasive & Easy Self-Collection Comes with a soft, skin-friendly collection swab for simple, comfortable sample gathering at home. Each kit includes detailed step-by-step guidance, making the whole self-test process simple, approachable and stress-free for daily personal use.
- ✅ Confidential & Discreet At-Home Monitoring Take charge of your personal intimate wellness with fully private home testing. No doctor appointments, no public waiting areas, and no awkward in-person checks. All testing can be done in your personal space for maximum privacy and comfort.
- ✅ Daily Feminine Wellness Management Perfect for regular intimate balance tracking or checking when you feel subtle physical discomfort. Designed for modern women to stay aware of personal body status, build better daily care habits, and maintain long-term intimate comfort and balance.
The company said the screening itself takes less than 30 minutes in its 2025 funding announcement. Its current website describes the full journey, including the virtual visit, as roughly an hour. These are company-reported estimates, not independent time studies. Reperio also says devices are returned for reuse; GeekWire reported that they are sterilized before reuse. GeekWire’s account of the funding describes the kit and return process.
ReperioCare: clinician review and follow-up
ReperioCare is the virtual-care layer. In the company’s described workflow, a user completes the screening, sees results in the app, and then has a virtual preventive visit with a licensed provider. That makes the offering closer to at-home preventive screening paired with telehealth than to traditional home health, where nurses or aides visit a patient’s home.
Rank #2
- Tests for the Most Common STDs: An easy-to-use common STD test with simple, high quality accurate, and private results. Simple HealthKit's Common STD Test screens for the most common and curable STDs / STIs: Chlamydia, Gonorrhea & Trichomoniasis
- Includes Telehealth: As part of our commitment to you. We are here from start to finish, no loose ends. If you receive a positive or abnormal test result, follow-up care is included. No extra charge. No hidden fees. It's that simple.
- Private & Easy To Use: Discreet, at-home testing that fits your life. Clear instructions, quick collection, and no awkward clinic visits. Just test, mail, and get answers.
- High Quality Results & Physician Approved, Test Intended for 18+ Only. Lab processing is included with your test purchase. Lab is CLIA Certified and CAP Accredited. Results delivered through a HIPAA-compliant portal.
- HSA / FSA Eligible: Use your HSA/FSA funds and save. A smarter, more affordable way to take care of your health without surprise costs.
Reperio’s website describes AI-assisted analysis, transcription, SOAP-note generation, and a clinician co-pilot. Those functions should not be confused with autonomous diagnosis: medical interpretation and care decisions remain the clinician’s responsibility. The company also describes its data integration as HIPAA-compliant; that representation is not, by itself, evidence of a particular independent security certification or audit. Reperio’s current website outlines its workflow and technology claims.
Who pays for the service
Reperio’s commercial model is primarily business-to-business or business-to-business-to-consumer. Employers, health plans, providers, and benefits platforms are potential buyers or partners. The company says kits are commonly sponsored by an employer or health plan and usually offered to eligible employees or members without a direct charge to them. Individuals can also inquire through Reperio, and the company has described access for some ICHRA members through Thatch.
The Tool Desk
Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →“No direct cost” depends on the sponsoring arrangement and eligibility; it does not mean the service is universally free. Reperio’s current website says ReperioCare can be billed as a preventive claim, but coverage and reimbursement depend on the plan, provider, state, member eligibility, and applicable billing rules. The company does not publish a list price on the cited organization demo page; the sales path is a consultation or demo rather than a transparent self-serve checkout. Reperio’s demo page is aimed at organizational buyers.
Rank #3
- Clinical Grade Stool Test Kit - Colonox FIT by Diagnox is an at-home stool test kit that detects hidden or occult blood in your stool, which may be a sign of GI or colorectal disorders.
- Affordable Complete Kit - Colonox FIT has everything you need. The kit includes a collection tube, antibody test, and collection apper with instructions for quick and seamless sampling & testing.
- Rapid & Easy to Read Results - Get accurate and easy-to-read results within 10 min. Look for two lines for a positive result, indicating the presence of blood, or only one line for a negative result.
- Highly Sensitive - The Colonox FIT uses antibodies to detect hemoglobin in your stool. This clinical-grade test is sensitive enough to detect hemoglobin concentrations as low as 45 ng/mL.
- Certified CLIA Waived - The Colonox FIT is a CLIA-waived test and FDA-cleared for home use. Gain reliable medical-grade insights from the comfort of your home.
What Reperio has reported about traction
In its funding announcement, Reperio reported more than 40 launches and thousands of screenings in its first 18 months of commercialization. It also cited a “near-perfect” renewal rate, 95% customer satisfaction, preventive-screening participation increases above 200% among clients, and a claimed return on investment of four to eight times.
These are company-reported figures. The public announcement does not provide the denominators, survey methods, comparison groups, time periods, or financial methodology needed to establish how broadly they apply. For example, a participation increase is difficult to interpret without the starting rate and comparator, while an ROI figure requires knowing whether it counts medical-cost avoidance, productivity, benefit utilization, or modeled savings. The claims are useful indicators of what Reperio says it is achieving, but they are not independently verified evidence of clinical or financial superiority.
Rank #4
- FOR WOMEN AND MEN: This private at-home kit is made for anyone wanting a simple way to support their health. It lets you complete the process from the comfort of home, offering a discreet and convenient option that fits naturally into your life.
- SIMPLE COLLECTION: Uses a quick urine sample you collect yourself, no special preparation needed. The process is clear and easy to follow, making it stress-free and convenient while helping you stay informed in a way that fits into your daily routine.
- FAST RESULTS: After mailing your sample with the included prepaid envelope, you’ll receive your results from our CLIA-certified lab in about two days through a secure online portal. This discreet, private, and quick process makes it easier to stay on top of your personal health.
- ALL-IN-ONE KIT: Each kit includes a collection cup, urine transport tube, prepaid return envelope, and a step-by-step instruction booklet. Everything is packaged to help you complete the process easily, confidently, and privately from your own home.
- CARE YOU CAN TRUST: From Better Life Science, a brand devoted to creating thoughtful, easy-to-use tools that support your well-being. Our at-home kits are designed to help you care for yourself with simplicity, convenience, and attention to privacy.
Nationwide kit availability is not the same as nationwide care
In an October 14, 2025 update, Reperio said its kit was available in all 50 states and ReperioCare had reached 39 states plus Washington, D.C. The company’s current website now describes ReperioCare as operating in all 50 states. Those statements show how the company’s coverage claims changed over time, but they do not establish independent measures of provider density, appointment availability, payer coverage, or completed visits in each state. The October 2025 expansion announcement gives the 39-state-plus-D.C. figure.
Quick wins for a faster PC:
Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Clear out junk files and repair common Windows errorsFree Scan →For a buyer or member, “available” can mean several different things: a kit can be shipped, a licensed clinician can serve a patient, a health plan can cover a visit, or a claim can be reimbursed. These are not interchangeable. A national footprint is meaningful only if the relevant service, provider, and payment arrangement are available to the particular population.
Best Value
- AT-HOME KIT: One small hair sample. 1,000+ everyday items. A fast, non-invasive way to explore possible wellness signals related to foods, drinks, nutrients, household items, and general gut-wellness factors—right from home.
- WHY PEOPLE LOVE THIS: If you’ve ever been told “you’re fine” but don’t feel it, this may be your next wellness tool. Your interactive report highlights indicators and wellness connections that may help you understand what’s supporting you—and what may be holding you back.
- 3 STEPS. ZERO STRESS: 1. Register – Activate your kit in your customer portal. 2. Collect – Snip 10 strands of hair. 3. Mail – Use the prepaid return envelope included. Simple, fast, and designed for at-home convenience. Colored, body or facial hair accepted.
- 72 HOUR WELLNESS INSIGHT REPORT: Receive clear, color-coded wellness insights uploaded to your portal within 72 hours of sample receipt. Your interactive clickable report makes it easy to click and learn more about each item.
- NOT A BIG TECH LAB. A FAMILY-RUN WELLNESS BRAND: We’re family-owned—not a data giant. Independently recognized to ISO/IEC 27001 for data protection. Your data is private and never sold. Trusted and used by holistic, chiropractic, and functional wellness professionals as a complementary tool to support everyday wellness conversations
Why the expansion is operationally demanding
The kit addresses one barrier to preventive screening: getting a measurement done without coordinating an onsite event or separate clinic visit. The more difficult scale-up is connecting that measurement to timely, appropriate care. Reperio’s model depends on a chain that includes delivery and return logistics, usable readings, clinician availability, state licensure, benefit eligibility, and follow-up when a result requires additional attention.
- Measurement and confirmation: Self-administered readings depend on correct setup, positioning, sample collection where applicable, and device pairing. A screening result is not necessarily a diagnosis and may need confirmation through laboratory testing or an in-person examination.
- Abnormal or urgent results: Buyers should understand how technically invalid readings, abnormal measurements, and symptoms requiring urgent evaluation are escalated, and how quickly a clinician responds.
- Access and usability: The model may be harder for people without a compatible smartphone, reliable internet, or sufficient digital confidence. A focused cardiometabolic panel is not a substitute for a broad physical examination or a comprehensive lab menu.
- Coverage and administration: State licensure, provider availability, plan design, eligibility checks, contracting, and claims handling can all affect whether a member can complete the virtual-care portion and how it is paid for.
- Data and AI governance: The service combines biometric and health information with clinician documentation and AI-assisted functions. A prospective buyer should review consent, data retention, secondary use, security controls, subcontractors, and whether data is used to train or improve AI systems.
- Reusable equipment: Return shipping, sanitation, loss, damage, and turnaround times can affect both operations and economics. Public materials cited here do not establish those costs or return rates.
Later developments and what they do—and do not—show
In its October 2025 expansion announcement, Reperio said it had added former Optum executive Larry Cohen to its health-plan advisory group and appointed Jocelyne Wood senior vice president of provider and health-plan operations. Those roles are consistent with the licensing, network, and payer work required for expansion, but do not by themselves demonstrate commercial scale.
Reperio’s press archive lists a 2026 partnership with Amazon One Medical involving at-home screenings and ongoing care. The archive establishes that the partnership was announced; it does not establish patient volume, revenue contribution, exclusivity, or the arrangement’s availability to other partners. Reperio’s press archive lists the later announcements.
Questions employers and health plans should ask
- Which specific devices are used, and what FDA clearances apply to each one?
- Which measurements are performed at home, and are any samples sent to a laboratory?
- What are the rates of failed tests, invalid readings, repeat measurements, and completed virtual visits?
- How are abnormal and urgent results escalated, and what service levels apply to clinician response?
- What percentage of kits are returned, successfully sanitized, and reused?
- Which states, plans, and member groups are currently eligible for ReperioCare?
- What does the reported increase of more than 200% in participation mean in absolute terms, and what was the baseline and comparator?
- How is the four-to-eight-times ROI calculated, and which costs or benefits are included?
- What are the per-member or per-screening costs, implementation fees, minimum population requirements, and renewal terms?
- What alternatives are available when a member needs in-person care, confirmatory laboratory testing, or help completing the kit?
Buyers should also compare the service against the workflow they actually need. Traditional laboratory networks may be more suitable when broad test menus and established specimen infrastructure are priorities; onsite biometric vendors may fit employers with accessible workforces and strong event participation; standalone telehealth may suffice when screening results already exist. These are different categories, not direct equivalents, and scope, pricing, coverage, and clinical processes should be checked for each vendor.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
